retatrutide phase 2 obesity trial results VisualAbstract: reduces body weight by 17.5% in patients with Retatrutide Results: 28.3% Weight Loss
Description
What Are Retatrutide's Side Effects
Obesity and Endothelial Function
Based on hazard ratios, this equates to roughly a 58% increased risk of developing all thyroid cancers and a 78% increased risk of developing medullary thyroid cancer compared to controls
Zheng Z-H, Tu J-L, Li X-H, Hua Q, Liu W-Z, Liu Y, et al
GLP-1RAs may be an optimal option for ischemic stroke treatment
Hot & tasty meal Delicious, nutritious lunch made simple
